Truls Sylvan Ingebrigtsen

2.6k total citations · 1 hit paper
42 papers, 1.8k citations indexed

About

Truls Sylvan Ingebrigtsen is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Truls Sylvan Ingebrigtsen has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 24 papers in Physiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Truls Sylvan Ingebrigtsen's work include Chronic Obstructive Pulmonary Disease (COPD) Research (36 papers), Asthma and respiratory diseases (21 papers) and Respiratory Support and Mechanisms (18 papers). Truls Sylvan Ingebrigtsen is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (36 papers), Asthma and respiratory diseases (21 papers) and Respiratory Support and Mechanisms (18 papers). Truls Sylvan Ingebrigtsen collaborates with scholars based in Denmark, United Kingdom and Sweden. Truls Sylvan Ingebrigtsen's co-authors include Jørgen Vestbo, Peter Lange, Jacob Louis Marott, Børge G. Nordestgaard, Morten Dahl, Yunus Çolak, Jesper Hallas, Mette Thomsen, Kim Rose Olsen and Jens‐Ulrik Stæhr Jensen and has published in prestigious journals such as JAMA, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Truls Sylvan Ingebrigtsen

41 papers receiving 1.7k citations

Hit Papers

Prediction of the Clinica... 2012 2026 2016 2021 2012 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification: A Study of the General Population
    2012 287 citations Peter Lange, Jacob Louis Marott et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Truls Sylvan Ingebrigtsen Denmark 22 1.5k 739 184 137 118 42 1.8k
Stuart Schembri United Kingdom 18 907 0.6× 444 0.6× 291 1.6× 55 0.4× 194 1.6× 43 1.5k
Deog Kyeom Kim South Korea 22 1.1k 0.7× 450 0.6× 267 1.5× 127 0.9× 78 0.7× 150 1.7k
R. Escamilla France 18 779 0.5× 430 0.6× 222 1.2× 84 0.6× 77 0.7× 62 1.1k
P Paoletti Italy 6 1.4k 0.9× 645 0.9× 107 0.6× 103 0.8× 80 0.7× 14 1.5k
Rebecca Normansell United Kingdom 18 824 0.6× 1.1k 1.4× 121 0.7× 72 0.5× 42 0.4× 27 1.7k
Hana Muellerova United Kingdom 18 1.2k 0.8× 571 0.8× 153 0.8× 84 0.6× 101 0.9× 30 1.3k
Bernardino Alcázar Navarrete Spain 24 1.3k 0.9× 747 1.0× 131 0.7× 72 0.5× 73 0.6× 116 1.5k
Juan Luis Rodríguez Hermosa Spain 20 1.0k 0.7× 444 0.6× 118 0.6× 60 0.4× 94 0.8× 90 1.3k
Wayomi R. Perera United Kingdom 9 1.7k 1.1× 838 1.1× 324 1.8× 310 2.3× 77 0.7× 13 1.9k
С. Н. Авдеев Russia 18 1.1k 0.7× 388 0.5× 316 1.7× 107 0.8× 125 1.1× 328 1.5k

Countries citing papers authored by Truls Sylvan Ingebrigtsen

Since Specialization
Citations

This map shows the geographic impact of Truls Sylvan Ingebrigtsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Truls Sylvan Ingebrigtsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Truls Sylvan Ingebrigtsen more than expected).

Fields of papers citing papers by Truls Sylvan Ingebrigtsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Truls Sylvan Ingebrigtsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Truls Sylvan Ingebrigtsen. The network helps show where Truls Sylvan Ingebrigtsen may publish in the future.

Co-authorship network of co-authors of Truls Sylvan Ingebrigtsen

This figure shows the co-authorship network connecting the top 25 collaborators of Truls Sylvan Ingebrigtsen. A scholar is included among the top collaborators of Truls Sylvan Ingebrigtsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Truls Sylvan Ingebrigtsen. Truls Sylvan Ingebrigtsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marott, Jacob Louis, Truls Sylvan Ingebrigtsen, Yunus Çolak, et al.. (2024). Predicting exacerbations in COPD in the Danish general population. Respiratory Medicine. 224. 107557–107557. 2 indexed citations
2.
Harboe, Zitta Barrella, Truls Sylvan Ingebrigtsen, Jon Torgny Wilcke, et al.. (2023). Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study. BMJ Open Respiratory Research. 10(1). e001814–e001814. 2 indexed citations
3.
Bülow, Anna von, Johannes Martin Schmid, Linda Makowska Rasmussen, et al.. (2023). Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies. CHEST Journal. 165(2). 253–266. 56 indexed citations
4.
Hansen, Susanne, Anna von Bülow, Ole Hilberg, et al.. (2023). Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma Register. The Journal of Allergy and Clinical Immunology In Practice. 12(1). 146–155.e5. 9 indexed citations
5.
Marott, Jacob Louis, Truls Sylvan Ingebrigtsen, Yunus Çolak, Jørgen Vestbo, & Peter Lange. (2021). Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis. American Journal of Respiratory and Critical Care Medicine. 204(8). 910–920. 72 indexed citations
6.
Eklöf, Josefin, Truls Sylvan Ingebrigtsen, Rikke Sørensen, et al.. (2021). Use of inhaled corticosteroids and risk of acquiringPseudomonas aeruginosain patients with chronic obstructive pulmonary disease. Thorax. 77(6). 573–580. 25 indexed citations
7.
Marott, Jacob Louis, Truls Sylvan Ingebrigtsen, Yunus Çolak, Jørgen Vestbo, & Peter Lange. (2020). Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality. American Journal of Respiratory and Critical Care Medicine. 202(2). 210–218. 59 indexed citations
8.
Ingebrigtsen, Truls Sylvan, Pradeesh Sivapalan, Ejvind Frausing Hansen, et al.. (2020). Use of Inhaled Corticosteroids and Risk of Acquiring Pseudomonas Aeruginosa in Patients with Chronic Obstructive Pulmonary Disease. University of Southern Denmark Research Portal (University of Southern Denmark). A2488–A2488. 2 indexed citations
9.
Çolak, Yunus, Shoaib Afzal, Jacob Louis Marott, et al.. (2019). Prognosis of COPD depends on severity of exacerbation history: A population-based analysis. Respiratory Medicine. 155. 141–147. 34 indexed citations
10.
Reilev, Mette, Anton Pottegård, Jesper Lykkegaard, et al.. (2019). Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD. Respirology. 24(12). 1183–1190. 52 indexed citations
11.
Lange, Peter, Yunus Çolak, Truls Sylvan Ingebrigtsen, Jørgen Vestbo, & Jacob Louis Marott. (2016). Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. The Lancet Respiratory Medicine. 4(6). 454–462. 114 indexed citations
12.
Tøttenborg, Sandra Søgaard, Peter Lange, Søren Paaske Johnsen, et al.. (2016). Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD. Respiratory Medicine. 119. 160–167. 59 indexed citations
13.
Ingebrigtsen, Truls Sylvan, Jacob Louis Marott, Børge G. Nordestgaard, et al.. (2014). Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study. European Respiratory Journal. 44(Suppl 58). 426–426. 1 indexed citations
14.
Lange, Peter, Jacob Louis Marott, Jørgen Vestbo, Truls Sylvan Ingebrigtsen, & Børge G. Nordestgaard. (2014). Socioeconomic Status and Prognosis of COPD in Denmark. COPD Journal of Chronic Obstructive Pulmonary Disease. 11(4). 431–437. 40 indexed citations
15.
Ingebrigtsen, Truls Sylvan, Jacob Louis Marott, Børge G. Nordestgaard, et al.. (2014). Statin use and exacerbations in individuals with chronic obstructive pulmonary disease. Thorax. 70(1). 33–40. 79 indexed citations
16.
Tøttenborg, Sandra Søgaard, et al.. (2014). [Physicians should increase focus on poor medicine adherence among chronically ill patients].. PubMed. 176(42). 3 indexed citations
17.
Ingebrigtsen, Truls Sylvan, Jacob Louis Marott, Jørgen Vestbo, et al.. (2013). Characteristics of Undertreatment in COPD in the General Population. CHEST Journal. 144(6). 1811–1818. 33 indexed citations
18.
Lange, Peter, Jacob Louis Marott, Jørgen Vestbo, et al.. (2012). Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification: A Study of the General Population. American Journal of Respiratory and Critical Care Medicine. 186(10). 975–981. 287 indexed citations breakdown →
19.
Ingebrigtsen, Truls Sylvan, Simon Francis Thomsen, Sophie van der Sluis, et al.. (2011). Genetic Influences on Pulmonary Function: A Large Sample Twin Study. Lung. 189(4). 323–330. 22 indexed citations
20.
Ingebrigtsen, Truls Sylvan, Simon Francis Thomsen, Jørgen Vestbo, et al.. (2010). Genetic influences on chronic obstructive pulmonary disease – A twin study. Respiratory Medicine. 104(12). 1890–1895. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stuart Schembri Breakdown of academic impact, for papers by Deog Kyeom Kim Breakdown of academic impact, for papers by R. Escamilla Breakdown of academic impact, for papers by P Paoletti Breakdown of academic impact, for papers by Rebecca Normansell Breakdown of academic impact, for papers by Hana Muellerova Breakdown of academic impact, for papers by Bernardino Alcázar Navarrete Breakdown of academic impact, for papers by Juan Luis Rodríguez Hermosa Breakdown of academic impact, for papers by Wayomi R. Perera Breakdown of academic impact, for papers by С. Н. Авдеев
Rankless by CCL
2026